Searched for
ENCUBE ETHICALS
Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...- Encube Ethicals stake sale on hold, IPO likely by 2027Global private equity firms including Warburg Pincus, EQT, and Partners Group had shown interest in acquiring the business at $1.5-1.6 bill...
- Warburg Pincus talks in final lap to buy Integrace Health for Rs 1,200 croreIntegrace is currently owned by homegrown PE fund True North and Singapore sovereign investor Temasek Holdings. True North Fund VI LLP hold...
- Warburg-Mubadala team up, emerge as frontrunner for EncubeThe consortium is competing against EQT. Mumbai-based pharma co likely to be valued at $1.8 bn. Binding bids are scheduled for next week.
- Frost & Sullivan recognises leading manufacturers and sustainability leaders at the 2025 IMEA and Sustainability 4.0 AwardsInside one of India’s earliest assessment-driven awards programmes honouring excellence across manufacturing, digital transformation, and s...
- Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
- Quadria Capital to pick up minority stake in drug company AragenQuadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...
- Encube announces its new R&D ‘Centre of Excellence’ at Lodha Lifesciences Hub, Palava
- Will PLI help Indian pharma gain market share at cost of MNCs?Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...
- Lodha, Encube Ethicals ink pact to develop 1-lakh-sq-ft R&D centre in 25-acre Lifesciences Hub in PalavaThe project is part of the Lodha Lifesciences Hub, which is spread across 25 acres and is Mumbai’s first systematically developed life scie...
- IPO pipeline expected to swell by over Rs 2 lakh crore in 2022: ReportThe year 2021 has seen the highest-ever IPO volumes in the country with the volumes surging to USD 15.3 billion, as against USD 4.2 billion...
- Encube Ethicals to buy Soframycin for Rs 125 crore for India & SL marketsEncube Ethicals has agreed to buy popular topical anti-microbial brand Soframycin and other brands from French drugmaker Sanofi for India a...
- How big is too big?We take a closer look into how the United States and India view and treat Big Tech companies.
- What’s behind the insurtech boom?In today's ETtech Morning Dispatch: Acko raises $200 million to become India's latest startup unicorn, Govt-Twitter spat set up escalate ov...
- Asia’s largest healthcare-focused fund sees a pandemic opportunity in IndiaQuadria Capital, which has backed Nobel Hygiene and Encube Ethicals within the last one week, plans to deploy $400-500 million in India ove...
- Encube Ethicals gets funding from Quadria Capital, others at $800 million valuationEncube Ethicals’ funding round, that saw participation of Quadria Capital and Gulf Islamic Investments, provides an exit to early backer Re...
- Multiples PE looks to exit Encube Ethicals at a valuation of $800 millionEncube Ethicals' promoter Mehul Shah will also sell about 5-10% stake in the company. A clutch of private equity funds, including Carlyle, ...
- Dr Reddy's launches generic arthritis drug in US market"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our con...
Load More
